ADC Therapeutics SA (ADCT) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$185.83M | +8.3% |
| 2024 | -$202.64M | -36.7% |
| 2023 | -$148.25M | -286.6% |
| 2022 | $79.45M | -48.4% |
| 2021 | $154.03M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$185.83M | +8.3% |
| 2024 | -$202.64M | -36.7% |
| 2023 | -$148.25M | -286.6% |
| 2022 | $79.45M | -48.4% |
| 2021 | $154.03M | — |